Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | S1PR1 | P21453 | 2/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.34 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.34 |
| ▸ | DRD2 | P14416 | 4/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | CPT2 | P23786 | 2/20 | 0.32 |
| ▸ | CPT1A | P50416 | 2/20 | 0.32 |
| ▸ | CPT1B | Q92523 | 2/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | BCL2 | P10415 | 1/20 | 0.32 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27433312 | 1.00 | S1PR1 (0.34) | S1PR1CYP2C9NOTUMDRD2TP53 | |
| SCHEMBL27432464 | 0.86 | KDM4E (0.43) | NOTUMDRD2MAPTALDH1A1CPT2 | |
| SCHEMBL30954108 | 0.86 | KDM4E (0.43) | NOTUMDRD2MAPTALDH1A1CPT2 | |
| SCHEMBL27433483 | 0.80 | TP53 (0.38) | NOTUMDRD2TP53BCL2MCL1 | |
| SCHEMBL27432668 | 0.80 | NOTUM (0.38) | NOTUMDRD2TP53MAPTL3MBTL1 | |
| SCHEMBL30954119 | 0.80 | NOTUM (0.38) | NOTUMDRD2TP53MAPTL3MBTL1 | |
| SCHEMBL30954043 | 0.80 | KDM4E (0.41) | CYP2C9DRD2MAPTALDH1A1 | |
| SCHEMBL27432942 | 0.80 | KDM4E (0.41) | CYP2C9DRD2MAPTALDH1A1 | |
| SCHEMBL30954080 | 0.77 | HSD17B10 (0.42) | DRD2MAPTALDH1A1 | |
| SCHEMBL27432967 | 0.77 | HSD17B10 (0.42) | DRD2MAPTALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4630412-A1 | COMPOUNDS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS | NMD Pharma A/S (DK) | 2025-10-15 | — | — | EP | claimed |
| WO-2024121130-A1 | COMPOUNDS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS | NMD PHARMA A/S (DK) | 2024-06-13 | — | — | WO | claimed |
| EP-4630412-A1 | COMPOUNDS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS | NMD Pharma A/S (DK) | 2025-10-15 | — | — | EP | disclosed |
| WO-2024121130-A1 | COMPOUNDS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS | NMD PHARMA A/S (DK) | 2024-06-13 | — | — | WO | disclosed |